Te AE - Search Results

1

Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes.

Hueber PA, Bienz MN, Valdivieso R, Lavigueur-Blouin H, Misrai V, Rutman M, Te AE, Chughtai B, Barber NJ, Emara AM, Munver R, Trinh QD, Zorn KC. Hueber PA, et al. Among authors: te ae. J Urol. 2015 Aug;194(2):462-9. doi: 10.1016/j.juro.2015.03.113. Epub 2015 Apr 4. J Urol. 2015. PMID: 25849599

2

Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index?

Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA. Choi J, et al. Among authors: te ae. Eur Urol. 2002 Jul;42(1):7-11. doi: 10.1016/s0302-2838(02)00222-1. Eur Urol. 2002. PMID: 12121722

3

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Among authors: te ae. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

4

The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

Sandhu JS, Te AE. Sandhu JS, et al. Among authors: te ae. Curr Urol Rep. 2004 Aug;5(4):274-9. doi: 10.1007/s11934-004-0050-6. Curr Urol Rep. 2004. PMID: 15260927 Review.

5

Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Te AE, et al. J Urol. 2004 Oct;172(4 Pt 1):1404-8. doi: 10.1097/01.ju.0000139541.68542.f6. J Urol. 2004. PMID: 15371855 Clinical Trial.

6

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

7

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. Among authors: te ae. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

8

Photoselective laser vaporization prostatectomy in men receiving anticoagulants.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. J Endourol. 2005 Dec;19(10):1196-8. doi: 10.1089/end.2005.19.1196. J Endourol. 2005. PMID: 16359214

9

Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.

Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Te AE, et al. BJU Int. 2006 Jun;97(6):1229-33. doi: 10.1111/j.1464-410X.2006.06197.x. BJU Int. 2006. PMID: 16686717

10

The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.

Lee R, Gonzalez RR, Te AE. Lee R, et al. Among authors: te ae. World J Urol. 2006 Sep;24(4):405-9. doi: 10.1007/s00345-006-0094-y. Epub 2006 May 13. World J Urol. 2006. PMID: 16699795 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters